![]() |
市場調査レポート
商品コード
1701442
医薬品包装市場の市場規模、シェア、成長分析:包装タイプ別、原材料別、投薬経路別、タイプ別、地域別 - 産業予測 2025~2032年Pharmaceutical Packaging Market Size, Share, and Growth Analysis, By Packaging Type (Primary, Secondary), By Raw Material (Plastic, Paper & Paperboard), By Drug Delivery, By Type, By Region - Industry Forecast 2025-2032 |
||||||
|
医薬品包装市場の市場規模、シェア、成長分析:包装タイプ別、原材料別、投薬経路別、タイプ別、地域別 - 産業予測 2025~2032年 |
出版日: 2025年04月02日
発行: SkyQuest
ページ情報: 英文 184 Pages
納期: 3~5営業日
|
医薬品包装市場規模は2023年に1,356億米ドルとなり、2024年の1,499億7,000万米ドルから2032年には3,357億8,000万米ドルに成長し、予測期間(2025~2032年)のCAGRは10.6%で推移する見通しです。
医薬品包装市場は、安定性と有効性を確保するために特殊な包装を必要とするバイオシミラーや生物製剤の需要増に牽引され、大きな成長を遂げています。センサーやRFIDタグなどの技術を搭載したスマート包装の革新は、医薬品の監視・管理をさらに強化し、市場拡大に寄与しています。しかし、包装コストと複雑さを高める厳しい規制要件が成長の課題となっています。さらに、先進パッケージング・ソリューションに関連する高コストが市場進出の妨げとなっています。とはいえ、新興国市場の好条件やスマート包装技術の開発が進んでいることは、医薬品包装業界の継続的成長の機会となっています。
Pharmaceutical Packaging Market size was valued at USD 135.6 billion in 2023 and is poised to grow from USD 149.97 billion in 2024 to USD 335.78 billion by 2032, growing at a CAGR of 10.6% during the forecast period (2025-2032).
The pharmaceutical packaging market has experienced significant growth, driven by the increasing demand for biosimilars and biologics that require specialized packaging to ensure their stability and efficacy. Innovations in smart packaging, featuring technologies such as sensors and RFID tags, have further enhanced the monitoring and management of pharmaceutical products, contributing to market expansion. However, stringent regulatory requirements that elevate packaging costs and complexities pose challenges to growth. Additionally, the high costs associated with advanced packaging solutions hinder market advancement. Nonetheless, favorable conditions in emerging markets and the ongoing development of smart packaging technologies present opportunities for continued growth in the pharmaceutical packaging industry.
Top-down and bottom-up approaches were used to estimate and validate the size of the Pharmaceutical Packaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Pharmaceutical Packaging Market Segments Analysis
Global Pharmaceutical Packaging Market is segmented by Packaging Type, Raw Material, Drug Delivery, Type and region. Based on Packaging Type, the market is segmented into Primary and Secondary. Based on Raw Material, the market is segmented into Plastic, Paper & Paperboard, Glass, Metals and Other Raw Materials. Based on Drug Delivery, the market is segmented into Oral, Pulmonary, Transdermal, Injectable, Topical, Nasal, Ocular/Ophthalmic, Intravenous and Other Drug Delivery Modes. Based on Type, the market is segmented into Plastic Bottles, Blister Packs, Labels & Accessories, Caps & Closures, Medical Specialty Bags, Prefilled Syringes, Temperature-Controlled Packaging, Pouches & Strip Packs, Ampoules, Vials, Prefilled Inhalers, Medication Tubes, Jars & Canisters, Cartridges and Other Types. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Pharmaceutical Packaging Market
The pharmaceutical packaging market is being propelled by heightened concerns regarding drug safety, particularly issues related to tampering and counterfeiting. This demand for secure packaging is driving the adoption of advanced solutions such as anti-counterfeiting measures and tamper-evident technologies. Additionally, the integration of modern advancements like smart packaging, which incorporates features such as sensors and RFID tags, is increasingly embraced by pharmaceutical manufacturers. These innovations not only enhance the security of drug products but also contribute significantly to the overall growth of the pharmaceutical packaging market, as companies seek to ensure the integrity and safety of their offerings.
Restraints in the Pharmaceutical Packaging Market
The Pharmaceutical Packaging market faces significant restraints due to fluctuations in the prices of raw materials such as glass, plastics, and metals, which are influenced by shifting market conditions. These price variations can have a substantial impact on packaging costs and overall profitability. Additionally, implementing advanced technologies into existing packaging processes may require considerable investments in new machinery and employee training. This transition can also be challenging and complex, potentially deterring companies from adopting innovative solutions to enhance their packaging methods. Consequently, these factors could hinder growth and development within the pharmaceutical packaging sector.
Market Trends of the Pharmaceutical Packaging Market
The pharmaceutical packaging market is increasingly influenced by advancements in pharmacogenomics (PGx), which is revolutionizing personalized medicine. As the push for individualized therapies grows to mitigate adverse drug reactions (ADRs), pharmaceutical companies are recognizing the need for specialized packaging solutions that safeguard and clearly communicate tailored dosing regimens. This trend is driving innovation in packaging materials and technologies, focusing on enhanced safety features, child-resistance, and user-friendly designs that accommodate complex dosing instructions. Additionally, as regulatory requirements tighten around personalized therapies, pharmaceutical packaging must adapt to ensure compliance while promoting patient adherence and education, presenting ample opportunities for market growth and development.